HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hironori Haga Selected Research

Carrier Proteins (Binding Protein)

3/2024Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.
1/2021The Expression of Insulin-Like Growth Factor 2 Messenger RNA-Binding Protein 3 in Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma.
3/2020IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hironori Haga Research Topics

Disease

70Neoplasms (Cancer)
04/2024 - 08/2005
14Fibrosis (Cirrhosis)
10/2023 - 02/2009
10Breast Neoplasms (Breast Cancer)
01/2024 - 02/2015
10Hepatitis
08/2017 - 03/2009
9Hepatocellular Carcinoma (Hepatoma)
10/2023 - 06/2006
8Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2024 - 06/2005
8Liver Diseases (Liver Disease)
11/2020 - 07/2004
7Adenocarcinoma of Lung
03/2024 - 06/2014
7Lymphoma (Lymphomas)
01/2018 - 12/2005
6B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 10/2008
6Lung Neoplasms (Lung Cancer)
12/2023 - 08/2013
6Hepatitis C
07/2016 - 03/2008
5Neoplasm Metastasis (Metastasis)
12/2023 - 02/2014
4Inflammation (Inflammations)
10/2023 - 03/2008
4Fever (Fevers)
05/2023 - 04/2008
4type 2C Congenital disorder of glycosylation
01/2022 - 03/2013
4Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
03/2021 - 01/2014
4Ascites
05/2020 - 01/2007
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2020 - 03/2005
4Sclerosing Cholangitis
12/2017 - 08/2006
4Adenocarcinoma
01/2014 - 03/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 08/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024 - 10/2008
3Triple Negative Breast Neoplasms
01/2024 - 07/2021
3Cholangiocarcinoma
10/2023 - 03/2008
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2023 - 03/2021
3End Stage Liver Disease
01/2023 - 09/2003
3Carcinoma (Carcinomatosis)
07/2022 - 01/2014
3Stomach Neoplasms (Stomach Cancer)
12/2019 - 01/2013
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 10/2008
3Immunoglobulin G4-Related Disease
01/2018 - 01/2016
3Mastocytosis
01/2018 - 03/2013
3Hypoxia (Hypoxemia)
01/2015 - 05/2005
3Budd-Chiari Syndrome (Budd Chiari Syndrome)
10/2010 - 04/2002
3Autoimmune Hepatitis
08/2006 - 07/2003
2Ulcer
04/2024 - 08/2021
2Rheumatoid Arthritis
04/2024 - 12/2012
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
08/2023 - 07/2018
2Teratoma (Teratoid Tumor)
05/2023 - 08/2022
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2023 - 12/2012
2Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 12/2019
2Ewing Sarcoma (Sarcoma, Ewing)
10/2021 - 08/2015
2Thrombosis (Thrombus)
01/2021 - 06/2009
2Lymphatic Metastasis
01/2021 - 08/2015
2Liver Neoplasms (Liver Cancer)
12/2020 - 01/2011
2Jaundice (Icterus)
11/2020 - 04/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2018

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2005
8Messenger RNA (mRNA)IBA
03/2024 - 12/2005
7RNA (Ribonucleic Acid)IBA
10/2023 - 10/2008
6Methotrexate (Mexate)FDA LinkGeneric
04/2024 - 12/2012
6AntibodiesIBA
03/2024 - 11/2012
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 01/2007
5CytokinesIBA
01/2024 - 03/2008
5Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2015
5AntigensIBA
08/2022 - 02/2009
5Antiviral Agents (Antivirals)IBA
10/2014 - 09/2002
4Tyrosine Kinase InhibitorsIBA
12/2022 - 07/2013
4DNA (Deoxyribonucleic Acid)IBA
12/2020 - 03/2008
4SteroidsIBA
01/2018 - 03/2009
4InterferonsIBA
10/2014 - 03/2008
3Carrier Proteins (Binding Protein)IBA
03/2024 - 03/2020
3Transcription Factors (Transcription Factor)IBA
02/2024 - 03/2011
3beta CateninIBA
12/2023 - 06/2021
3Hematoxylin (Haematoxylon)IBA
11/2023 - 01/2019
3Eosine Yellowish-(YS) (Eosin)IBA
11/2023 - 01/2019
3Cadherins (E-Cadherin)IBA
10/2023 - 12/2015
3Immune Checkpoint InhibitorsIBA
06/2023 - 11/2020
3S100 Proteins (S 100 Protein)IBA
05/2023 - 05/2018
3Tumor Biomarkers (Tumor Markers)IBA
08/2022 - 01/2011
3Paclitaxel (Taxol)FDA LinkGeneric
08/2021 - 01/2015
3Trastuzumab (Herceptin)FDA Link
08/2021 - 01/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 04/2013
3LigandsIBA
01/2020 - 03/2013
3MucinsIBA
07/2018 - 01/2013
3Cytidine DeaminaseIBA
01/2018 - 02/2007
3Anaplastic Lymphoma KinaseIBA
07/2017 - 08/2005
3human ERBB2 proteinIBA
02/2015 - 01/2013
3Ribavirin (Virazole)FDA LinkGeneric
10/2014 - 03/2008
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2014 - 02/2007
2B7-H1 AntigenIBA
04/2024 - 07/2022
2FibrinIBA
04/2024 - 06/2023
2Estrogen ReceptorsIBA
12/2023 - 09/2018
2VimentinIBA
10/2023 - 12/2015
2ChemokinesIBA
10/2023 - 01/2016
2Immunoglobulin M (IgM)IBA
01/2023 - 04/2011
2Rituximab (Mabthera)FDA Link
01/2023 - 04/2007
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
08/2022 - 01/2022
2Insulin-Like PeptidesIBA
05/2022 - 01/2021
2Leukemia Inhibitory FactorIBA
01/2022 - 01/2020
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2021 - 02/2016
2HLA-G Antigens (HLA G)IBA
01/2020 - 08/2015
2Serine Proteases (Serine Protease)IBA
01/2020 - 09/2015

Therapy/Procedure

51Liver Transplantation
10/2023 - 04/2002
19Therapeutics
12/2023 - 08/2006
9Transplantation
08/2017 - 09/2002
7Drug Therapy (Chemotherapy)
05/2023 - 09/2005
4Neoadjuvant Therapy
11/2023 - 01/2015
3Organ Transplantation
01/2021 - 06/2005
2Hepatectomy
02/2023 - 08/2016